Understanding Metabolic Drivers of Osteosarcoma Tumors
Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.
Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.
Researchers will determine if a promising new drug used to treat dogs with hemangiosarcoma would benefit dogs with other incurable cancers.
Researchers will find out how the specific enzymes in dogs break down common environmental chemicals that have been linked to cancers in humans.
Researchers will study the potential of a novel type of stem cell to treat inflammatory and immune-mediated diseases in dogs.
Researchers will investigate how hemangiosarcoma cells use cholesterol and lipids to promote tumor growth and look at ways to block tumor cells from using these metabolic fuels.
Researchers are looking at changes in gut bacteria that stimulate the immune system in dogs with inflammatory bowel disease to help identify novel ways to diagnose and treat this disease.
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.